SMARCA4 and neoplasm: By immunohistochemistry, the tumor cells showed a high (60%) Ki-67 proliferation index, retained INI-1 expression, wild-type p53 expression, focal CD10 expression, and loss of the expression of BRG1, CK-pan, synaptophysin, desmin, and ER (Fig. 2).